Harvard Bioscience Inc
HBIO· Nasdaq
HBIOHarvard Bioscience Inc
Released May 12, 2025, before the open
10-Q filed May 12, 2025, 42 days after period end · 0001171843-25-003093
| Metric | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 |
|---|---|---|---|---|
| Revenue | $21.77M | $24.51M | $29.98M | $28.78M |
| Net Income | -$50.34M | -$4.69M | $622.00K | -$6.88M |
| EPS Diluted |
Harvard Bioscience Inc · CIK 1123494 · Engraved from SEC EDGAR
| -$11.42 |
| -$0.11 |
| $0.01 |
| -$0.17 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
